Search Publications

Filter Publications

By Year
Blasco MTeresa, Navas C, Martín-Serrano G, Graña-Castro O, Lechuga CG, Martín-Díaz L, Djurec M, Li J, Morales-Cacho L, Esteban-Burgos L, Perales-Patón J, Bousquet-Mur E, Castellano E, Jacob HKC, Cabras L, Musteanu M, Drosten M, Ortega S, Mulero F, Sainz B, Dusetti N, Iovanna J, Sanchez-Bueno F, Hidalgo M, Khiabanian H, Rabadan R, Al-Shahrour F, Guerra C, Barbacid M.  2019.  Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF.. Cancer Cell. 35(4):573-587.e6.▶ Go to Pubmed
Klein HL, Bačinskaja G, Che J, Cheblal A, Elango R, Epshtein A, Fitzgerald DM, Gómez-González B, Khan SR, Kumar S, Leland BA, Marie L, Mei Q, Miné-Hattab J, Piotrowska A, Polleys EJ, Putnam CD, Radchenko EA, Saada AAit, Sakofsky CJ, Shim EYong, Stracy M, Xia J, Yan Z, Yin Y, Aguilera A, Argueso JLucas, Freudenreich CH, Gasser SM, Gordenin DA, Haber JE, Ira G, Jinks-Robertson S, King MC, Kolodner RD, Kuzminov A, Lambert SAe, Lee SEun, Miller KM, Mirkin SM, Petes TD, Rosenberg SM, Rothstein R, Symington LS, Zawadzki P, Kim N, Lisby M, Malkova A.  2019.  Guidelines for DNA recombination and repair studies: Cellular assays of DNA repair pathways.. Microb Cell. 6(1):1-64.▶ Go to Pubmed
Sapienza MRosaria, Abate F, Melle F, Orecchioni S, Fuligni F, Etebari M, Tabanelli V, Laginestra MAntonella, Pileri A, Motta G, Rossi M, Agostinelli C, Sabattini E, Pimpinelli N, Truni M, Falini B, Cerroni L, Talarico G, Piccioni R, Amente S, Indio V, Tarantino G, Brundu F, Paulli M, Berti E, Facchetti F, Dellino GIvan, Bertolini F, Tripodo C, Rabadan R, Pileri SA.  2018.  Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.. Haematologica. ▶ Go to Pubmed
Lee J-K, Liu Z, Sa JK, Shin S, Wang J, Bordyuh M, Cho HJin, Elliott O, Chu T, Choi SWon, Rosenbloom DIS, Lee I-H, Shin YJae, Kang HJu, Kim D, Kim SYoung, Sim M-H, Kim J, Lee T, Seo YJee, Shin H, Lee M, Kim SHeon, Kwon Y-J, Oh J-W, Song M, Kim M, Kong D-S, Choi JWon, Seol HJun, Lee J-I, Kim STae, Park JOh, Kim K-M, Song S-Y, Lee J-W, Kim H-C, Lee JEon, Choi MGew, Seo SWook, Shim YMog, Zo JIll, Jeong BChang, Yoon Y, Ryu GHa, Kim NKD, Bae JSeol, Park W-Y, Lee J, Verhaak RGW, Iavarone A, Lee J, Rabadan R, Nam D-H.  2018.  Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.. Nat Genet. 50(10):1399-1411.▶ Go to Pubmed
Alvarez MJ, Subramaniam PS, Tang LH, Grunn A, Aburi M, Rieckhof G, Komissarova EV, Hagan EA, Bodei L, Clemons PA, Cruz FSDela, Dhall D, Diolaiti D, Fraker DA, Ghavami A, Kaemmerer D, Karan C, Kidd M, Kim KM, Kim HC, Kunju LP, Langel Ü, Li Z, Lee J, Li H, LiVolsi V, Pfragner R, Rainey AR, Realubit RB, Remotti H, Regberg J, Roses R, Rustgi A, Sepulveda AR, Serra S, Shi C, Yuan X, Barberis M, Bergamaschi R, Chinnaiyan AM, Detre T, Ezzat S, Frilling A, Hommann M, Jaeger D, Kim MK, Knudsen BS, Kung AL, Leahy E, Metz DC, Milsom JW, Park YS, Reidy-Lagunes D, Schreiber S, Washington K, Wiedenmann B, Modlin I, Califano A.  2018.  A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.. Nat Genet. ▶ Go to Pubmed
Rajbhandari P, Lopez G, Capdevila C, Salvatori B, Yu J, Rodriguez-Barrueco R, Martinez D, Yarmarkovich M, Weichert-Leahey N, Abraham BJ, Alvarez MJ, Iyer A, Harenza JLynne, Oldridge D, De Preter K, Koster J, Asgharzadeh S, Seeger RC, Wei JS, Khan J, Vandesompele J, Mestdagh P, Versteeg R, A Look T, Young RA, Iavarone A, Lasorella A, Silva JM, Maris JM, Califano A.  2018.  Cross-cohort analysis identifies a TEAD4 ↔ MYCN positive-feedback loop as the core regulatory element of high-risk neuroblastoma.. Cancer Discov. ▶ Go to Pubmed

Pages